Ultrasound-guided, intraglandular injection of botulinum toxin A in children suffering from excessive salivation

Journal of Laryngology and Otology

Volumn 121, Issue 10, 2007, Pages 947-951

  Gerlinger, I ^a,b   Szalai, G ^a   Hollody K ^a   Nemeth A ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Botulinum Toxin A; Sialorrhoea; Submandibular Gland; Ultrasonography

Indexed keywords

BOTULINUM TOXIN A; IMMUNOGLOBULIN A; SALIVA PROTEIN; MUSCLE RELAXANT AGENT;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HUMAN; HYPERSALIVATION; MALE; NONHUMAN; PAROTID GLAND; PROTEIN CONTENT; QUALITY OF LIFE; RABBIT; SUBMANDIBULAR GLAND; ANIMAL; DOSE RESPONSE; ENDOSCOPIC ECHOGRAPHY; PRESCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ANIMALS; BOTULINUM TOXIN TYPE A; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; NEUROMUSCULAR AGENTS; SIALORRHEA; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 38449111401     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215107006949     Document Type: Article

References (21)

1. Ellies M, Laskawi R, Rohrbach-Volland S, Arglebe C, Beuche W. Botulinum toxin to reduce saliva flow: selected indications for ultrasound guided toxin application into salivary glands. Laryngoscope 2002;112:82-6
2. Jongerius PH, Rotteveel JJ, Joosten F. Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy - presentation of a case series. Eur J Pediatr 2001;160:509-12
3. Jongherius PH, Joosten F, Hoogen FJA. The treatment of drooling by ultrasound-guided intraglandular injections of botulinum toxin type A into the salivary glands. Laryngoscope 2003;113:107-11
4. Jost WH, Kohl A. Botulinum toxin: evidence-based medicine criteria in rare indications. J Neurol 2001;248(suppl 1):39-44
5. Guntinas-Lichius O. Injection of botulinum toxin type B for the treatment of otolaryngology patients with secondary treatment failure of botulinum toxin type A. Laryngoscope 2003;113:743-5
6. Blitzer A, Sulica L. Botulinum toxin: basic science, and clinical uses in otolaryngology. Laryngoscope 2001;111:218-26
7. Bushara KO. Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment - botulinum toxin A injections of the parotid glands. Med Hypotheses 1997;48:337-9
8. Dedo HH. Recurrent laryngeal nerve section for spastic dysphonia. Ann Otol Rhinol Laryngol 1976;85:451-9
9. Greene PE, Fahn S, Diamond B. Development of resistance to botulinum toxin A in patients with torticollis. Mov Disord 1994;9:213-17
10. Tan EK, Lo YL, Seah A, Auchus AP. Recurrent jaw dislocation after botulinum toxin treatment for sialorrhea in amyotrophic lateral sclerosis. J Neurol Sci 2001;190:95-7
11. Beuche W, Arglebe C, Laskawi R. Quantitative reduction in saliva production in two ALS patients with intraglandular injections of botulinum toxin. Neur Psychiatr Brain Res 2000;8:23-6
12. Porta M, Gamba M, Bertacci G, Vaj P. Treatment of sialorrhea with ultrasound guided botulinum toxin type A injections in patients with neurological disorders. J Neurol Neurosurg Psychiatry 2001;70:538-42
13. Ellies M, Laskawi R, Götz W, Arglebe C, Tormählen G. Immunohistochemical and morphometric investigations of the influence of botulinum toxin on the submandibular gland of the rat. Eur Arch Otorhinolaryngol 1999;25:148-53
14. Jost WH. Treatment of drooling in Parkinson's disease with botulinum toxin. Mov Disord 1999;14:1057
15. Laskawi R, Drobik C, Schönebeck C. Up-to-date report of botulinum toxin treatment in patients with gustatory sweating. Laryngoscope 1988;108:381-5
16. Laskawi R, Ellies M, Drobik C. Botulinum toxin treatment in patients with hemifacial spasm. Eur Arch Otorhinolaryngol 1994;251:271-5
17. Akin I, Esmer N, Gerceker M. Sialographic and ultrasonographic analyses of major salivary glands. Acta Otolaryngol 1991;111:600-6
18. Koischwitz D, Gritzmann N. Ultrasound of the neck. Radiol Clin North Am 2000;38:1029-45
19. Daelen B, Thorwirth W, Koch A. Treatment of recurrent dislocation of the temporomandibular joint with type A botulinum toxin. Int J Maxillofac Surg 1997;2:458-60
20. De M, Adair R, Golchin K. Outcomes of submandibular duct relocation: a 15 year experience. J Laryngol Otol 2003;117:821-3
21. Shirley WP, Hill JS, Woolley AL. Success and complications of four duct ligation for sialorrhea. Int J Pediatr Otorhinolaryngol 2003;1:1-6